Palisade Bio (PALI) Cash & Equivalents (2010 - 2026)
Palisade Bio (PALI) reported Cash & Equivalents of $125.2 million for Q2 2026, compared with $5.42 million a year earlier and down 5.6% from the prior quarter.
Powered by 
Analysis
Palisade Bio (PALI) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2025, Palisade Bio posted Cash & Equivalents of $133.39 million.
- Cash & Equivalents has a five-year compound annual growth rate of 184.7% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $9.82 million in FY2024 (-21.0%), $12.43 million in FY2023 (+0.4%), $12.38 million in FY2022 (+18.0%) and $10.5 million in FY2021.
- Five-year quarterly Cash & Equivalents spans a low of $4.98 million in Q2 2022 and a high of $133.39 million in Q4 2025.
- The high point for year-over-year Cash & Equivalents in five years was Q1 2022 (growth of 980.3%); the low point was Q2 2022 (a decline of 60.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $132.63 million (Q1 2026), $133.39 million (Q4 2025) and $5.23 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Palisade Bio | 249.98 Mn | -146.46 Mn | - | 125.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 125.20 Mn |
| Mar 31, 2026 | 132.63 Mn |
| Dec 31, 2025 | 133.39 Mn |
| Sep 30, 2025 | 5.23 Mn |
| Jun 30, 2025 | 5.42 Mn |
| Mar 31, 2025 | 7.23 Mn |
| Dec 31, 2024 | 9.82 Mn |
| Sep 30, 2024 | 8.04 Mn |
| Jun 30, 2024 | 11.35 Mn |
| Mar 31, 2024 | 11.28 Mn |
| Dec 31, 2023 | 12.43 Mn |
| Sep 30, 2023 | 15.31 Mn |
| Jun 30, 2023 | 16.40 Mn |
| Mar 31, 2023 | 13.30 Mn |
| Dec 31, 2022 | 12.38 Mn |
| Sep 30, 2022 | 13.99 Mn |
| Jun 30, 2022 | 4.98 Mn |
| Mar 31, 2022 | 6.64 Mn |
| Dec 31, 2021 | 10.50 Mn |
| Sep 30, 2021 | 14.10 Mn |
API Access
Palisade Bio Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PALI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "PALI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PALI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();